SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

SGP Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

SpyGlass Pharma, Inc. Common StockNASDAQ: SGP

Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026

Cost of revenue of $318K in Q1 FY2026

Q1 FY2026 cost of revenue was $318K.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$318K+46.7% QoQ
Last fiscal yearDec 2025
$612K— YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
612K USD
Year-over-year change
—

Cost of Revenue vs competitors

How SGP compares with its peers on the latest reported figures

  • Peers report in different currencies, so cost of revenue is compared through growth and share of revenue rather than absolute size.
SGP Competitors
Cost of Revenue for SGP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ALCAlcon Inc.LTM Sep 2026$4.67B USD+2.1%+5.5%42.7%
BLCOBausch + Lomb CorporationLTM Jun 2026$2.28B USD+8.0%+15.0%42.8%
GKOSGlaukos CorporationLTM Jun 2026$127.96M USD+24.9%+18.3%20.9%
STAASTAAR Surgical CompanyLTM Apr 2026$68.44M USD-5.7%-2.2%23.6%
RXSTRxSight, Inc.LTM Mar 2026$29.3M USD-43.5%+4.4%23.0%
OCSOculis Holding AGLTM Mar 2026CHF 15.07M CHF——2989.4%
SGHTSight Sciences, Inc.LTM Mar 2026$11M USD-1.8%-4.7%13.8%
OCULOcular Therapeutix, Inc.LTM Mar 2026$6.64M USD+19.4%+13.1%12.8%
EYPTEyePoint Pharmaceuticals, Inc.LTM Mar 2026$1.79M USD-52.4%-37.2%23.5%
SGPSpyGlass Pharma, Inc. Common StockFY2025$612K USD———
Peer median (excluding SGP) —+0.2%+4.9%23.5%

Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Intrinsic Alpha fair value

Locked

Current Price

$29.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.